Medipal Holdings Overview

  • Status
  • Public
  • Employees
  • 21,393
  • Stock Symbol
  • 7459
Stock Symbol
  • Investments
  • 6
  • Share Price
  • $20.57
  • (As of Friday Closing)

Medipal Holdings General Information


Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Drug Delivery
Other Industries
Stock Exchange
Primary Office
  • 2-7-15, Yaesu Chuo-ku
  • Tokyo, 104-8461
  • Japan
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medipal Holdings Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$20.57 $20.60 $15.92 - $22.81 $4.32B 210M 587K $1.46

Medipal Holdings Financials Summary

In Thousands,
TTM 30-Sep-2020 FY 2020 31-Mar-2020 FY 2019 31-Mar-2019 FY 2018 31-Mar-2018
EV 3,491,681 3,563,308 4,687,443 4,188,612
Revenue 29,547,804 29,918,582 28,698,884 28,383,004
EBITDA 769,542 829,246 697,825 712,223
Net Income 309,031 349,187 309,895 313,749
Total Assets 15,631,242 15,214,514 14,591,616 15,233,087
Total Debt 302,212 317,248 386,789 526,838
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medipal Holdings Executive Team (1)

Name Title Board Seat Contact Info
Toshihide Yoda Senior Managing Director, General Manager - Business Development & Head - IR
To view Medipal Holdings’s complete executive team members history, request access »

Medipal Holdings Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medipal Holdings Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 10-Mar-2020 000000000 Drug Discovery
0000000000 0000000 27-Dec-2019 00000 00000 00 000.00 Biotechnology
000000 000000 15-Mar-2017 00000 0000000 000.00 Drug Discovery 000000000 0000
0000-000000 08-Nov-2013 000000000000000000 Storage (IT)
Sinopharm Holding Beijing Tianxingpuxin Bio-Med Company 26-Jul-2013 Secondary Transaction - Private Holding Companies
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Medipal Holdings Subsidiaries (1)

Company Name Industry Location Founded
0000-000000 Storage (IT) Tokyo, Japan 0000
To view Medipal Holdings’s complete subsidiaries history, request access »